Impact of concurrent medications on outcomes with PD1/PD-L1 inhibitors for metastatic urothelial carcinoma.

被引：10
|
作者：
Agarwal, Archana
Pond, Gregory Russell
Curran, Catherine
Nassar, Amin
Nuzzo, Pier Vitale
Kumar, Vivek
McGregor, Bradley Alexander
Wei, Xiao X.
Harshman, Lauren Christine
Choueiri, Toni K.
Kilbridge, Kerry L.
Sonpavde, Guru
机构：
[1] St Elizabeths Med Ctr, Dana Farber Canc Inst, Brighton, MA USA
[2] McMaster Univ, Hamilton, ON, Canada
[3] Dana Farber Canc Inst, Boston, MA 02115 USA
[4] Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA
[5] Dana Farber Canc Inst, Lank Ctr Genitourinary Malignancy, Boston, MA 02115 USA
[6] Dana Farber Canc Inst, Dept Genitourinary Oncol, Boston, MA 02115 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2019年 / 37卷 / 07期
关键词：
D O I：
10.1200/JCO.2019.37.7_suppl.435
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
435
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Discordance of high PD-L1 expression in primary and metastatic urothelial carcinoma lesions
    Burgess, Earle F.
    Livasy, Chad
    Hartman, Aaron
    Robinson, Myra M.
    Symanowski, James
    Naso, Caroline
    Doherty, Shannon
    Guerrieri, Renato
    Riggs, Stephen
    Grigg, Claud M.
    Clark, Peter E.
    Raghavan, Derek
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2019, 37 (05) : 299.e19 - 299.e25
  • [42] Inhibition of PD1:PD-L1 interaction by an E-coli-derived optimized PD1 variant
    Shwartz, Michal Brand
    Assor, Mayan
    Dotan, Nesly
    Ratzon, Einav
    Cohen, Elad
    Ruimi, Nili
    Bloch, Itai
    Gal, Maayan
    Yadid, Itamar
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2018, 506 (03) : 731 - 738
  • [43] PD-L1 expression and PD-1/PD-L1 inhibitors in breast cancer
    Monneur, Audrey
    Goncalves, Anthony
    Bertucci, Francois
    BULLETIN DU CANCER, 2018, 105 (03) : 261 - 272
  • [44] PD-L1 assessment in urothelial carcinoma: a practical approach
    Eckstein, Markus
    Cimadamore, Alessia
    Hartmann, Arndt
    Lopez-Beltran, Antonio
    Cheng, Liang
    Scarpelli, Marina
    Montironi, Rodolfo
    Gevaert, Thomas
    ANNALS OF TRANSLATIONAL MEDICINE, 2019, 7 (22)
  • [45] Expression of PD-L1 in primary urothelial carcinoma (UC).
    Zhang, Jingsong
    Dickinson, Shohreh I.
    Clark, Noel D.
    Flaherty, Amber Lea
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [46] PD-L1 testing in urothelial carcinoma: are we there yet?
    van Leenders, Geert J. L. H.
    TRANSLATIONAL ANDROLOGY AND UROLOGY, 2019, 8 : S466 - S468
  • [47] PD1/PD-L1抑制剂治疗肿瘤
    赵宇飞
    陈晓
    李薇
    中国肿瘤生物治疗杂志, 2017, 24 (08) : 904 - 911
  • [48] PD1/PD-L1 pathway in psoriasis and psoriatic arthritis: a review
    Adamczyk, Michal
    Krasowska, Dorota
    POSTEPY DERMATOLOGII I ALERGOLOGII, 2021, 38 (06): : 925 - 930
  • [49] PD1/PD-L1 Expressions in Plasmablastic Lymphoma with Clinicopathological Correlation
    Rosado, Flavia G.
    Coberly, Jared
    Gupta, Arjun
    John, George
    Naina, Harris
    Koduru, Prasad
    Chen, Weina
    ANNALS OF CLINICAL AND LABORATORY SCIENCE, 2021, 51 (02): : 174 - 181
  • [50] PD1/PD-L1 immunohistochemistry in thoracic oncology: Where are we?
    Hofman, Paul
    Ilie, Marius
    Lassalle, Sandra
    Long, Elodie
    Bence, Coraline
    Butori, Catherine
    Hofman, Veronique
    ANNALES DE PATHOLOGIE, 2017, 37 (01) : 39 - 45
12345